| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |